home / stock / prct / prct quote
Last: | $68.10 |
---|---|
Change Percent: | 0.13% |
Open: | $68.05 |
Close: | $68.10 |
High: | $68.835 |
Low: | $67.44 |
Volume: | 503,046 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$68.1 | $68.05 | $68.1 | $68.835 | $67.44 | 503,046 | 05-17-2024 |
$68.14 | $68.9 | $68.14 | $69.63 | $67.8 | 445,284 | 05-16-2024 |
$69.19 | $66.19 | $69.19 | $77 | $65.5301 | 994,714 | 05-15-2024 |
$65.31 | $63.96 | $65.31 | $66.085 | $63.96 | 497,613 | 05-14-2024 |
$63.5 | $63.02 | $63.5 | $64.6638 | $63 | 453,652 | 05-13-2024 |
$62.65 | $63.5 | $62.65 | $64.39 | $61.985 | 411,490 | 05-10-2024 |
$63 | $60.6 | $63 | $63.22 | $60.14 | 442,451 | 05-09-2024 |
$60.36 | $62.4 | $60.36 | $63.89 | $60.155 | 602,620 | 05-08-2024 |
$62.79 | $61.51 | $62.79 | $63.07 | $61.04 | 679,200 | 05-07-2024 |
$61.43 | $65 | $61.43 | $65 | $60.6 | 1,072,443 | 05-06-2024 |
$64.31 | $62.95 | $64.31 | $64.89 | $60.67 | 1,143,117 | 05-03-2024 |
$61.74 | $62.63 | $61.74 | $62.93 | $59.27 | 1,020,940 | 05-02-2024 |
$60.61 | $55 | $60.61 | $63.26 | $53.95 | 2,129,476 | 05-01-2024 |
$52.98 | $51.82 | $52.98 | $54 | $51.53 | 875,721 | 04-30-2024 |
$52.05 | $52.23 | $52.05 | $53.28 | $51.985 | 593,649 | 04-29-2024 |
$51.83 | $52.68 | $51.83 | $52.77 | $51.07 | 586,484 | 04-26-2024 |
$52.28 | $51.88 | $52.28 | $53 | $50.63 | 498,161 | 04-25-2024 |
$52.48 | $53.65 | $52.48 | $54.79 | $51.95 | 519,731 | 04-24-2024 |
$53.75 | $51.09 | $53.75 | $54.2 | $49.001 | 617,804 | 04-23-2024 |
$51.19 | $50.69 | $51.19 | $52.12 | $50.02 | 479,048 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
PROCEPT BioRobotics Corporation Company Name:
PRCT Stock Symbol:
NASDAQ Market:
SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (NASDAQ:PRCT) (the "Company"), a surgical robotics company focused ...
SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present ...